High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis – results from a 24-month, multicenter, open-label Danish study

PURPOSE: Treatment adherence is a prerequisite for treatment success and therefore an important consideration to assure that therapeutic goals are achieved both from a patient point of view and for optimal health care resource utilization. Published data on treatment adherence with fingolimod (Gilen...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, Karen, Kant, Matthias, Pfleger, Claudia, Jensen, Henrik Boye, Oesterberg, Ole, Hald, Anne Rieper, Nielsen, Frederik K, Rubak, Sune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029605/
https://www.ncbi.nlm.nih.gov/pubmed/29988735
http://dx.doi.org/10.2147/PPA.S166278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029605/
https://www.ncbi.nlm.nih.gov/pubmed/29988735
http://dx.doi.org/10.2147/PPA.S166278

Ejemplares similares